101 related articles for article (PubMed ID: 15942646)
21. Inhibitory effect of luteolin on hepatocyte growth factor/scatter factor-induced HepG2 cell invasion involving both MAPK/ERKs and PI3K-Akt pathways.
Lee WJ; Wu LF; Chen WK; Wang CJ; Tseng TH
Chem Biol Interact; 2006 Mar; 160(2):123-33. PubMed ID: 16458870
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of apoptosis-inducing factor translocation is involved in protective effects of hepatocyte growth factor against excitotoxic cell death in cultured hippocampal neurons.
Ishihara N; Takagi N; Niimura M; Takagi K; Nakano M; Tanonaka K; Funakoshi H; Matsumoto K; Nakamura T; Takeo S
J Neurochem; 2005 Dec; 95(5):1277-86. PubMed ID: 16135073
[TBL] [Abstract][Full Text] [Related]
23. Hepatocyte growth factor stimulates adenoviral-mediated gene transfer across the apical membrane of epithelial cells.
Burrus JK; Matheson WD; Hong JS; Sorscher EJ; Balkovetz DF
J Gene Med; 2004 Jun; 6(6):624-30. PubMed ID: 15170733
[TBL] [Abstract][Full Text] [Related]
24. Tumor-stroma interactions reduce the efficacy of adenoviral therapy through the HGF-MET pathway.
Yasui T; Ohuchida K; Zhao M; Onimaru M; Egami T; Fujita H; Ohtsuka T; Mizumoto K; Tanaka M
Cancer Sci; 2011 Feb; 102(2):484-91. PubMed ID: 21105966
[TBL] [Abstract][Full Text] [Related]
25. Hepatocyte growth factor gene therapy of liver cirrhosis in rats.
Ueki T; Kaneda Y; Tsutsui H; Nakanishi K; Sawa Y; Morishita R; Matsumoto K; Nakamura T; Takahashi H; Okamoto E; Fujimoto J
Nat Med; 1999 Feb; 5(2):226-30. PubMed ID: 9930873
[TBL] [Abstract][Full Text] [Related]
26. NK3 and NK4 of HGF enhance filamin production via STAT pathway, but not NK1 and NK2 in human breast cancer cells.
Yin YL; Chen HL; Kuo HM; He SP
Acta Pharmacol Sin; 2008 Jun; 29(6):728-35. PubMed ID: 18501120
[TBL] [Abstract][Full Text] [Related]
27. Significance of serum hepatocyte growth factor levels in patients with hepatocellular carcinoma undergoing hepatic resection.
Chau GY; Lui WY; Chi CW; Chau YP; Li AF; Kao HL; Wu CW
Eur J Surg Oncol; 2008 Mar; 34(3):333-8. PubMed ID: 17218078
[TBL] [Abstract][Full Text] [Related]
28. Vascular endothelial growth factor protects hepatoma cells against oxidative stress-induced cell death.
Osada S; Imai H; Tomita H; Tokuyma Y; Okumura N; Sakashita F; Nonoka K; Sugiyama Y
J Gastroenterol Hepatol; 2006 Jun; 21(6):988-93. PubMed ID: 16724983
[TBL] [Abstract][Full Text] [Related]
29. In vivo hepatic HB-EGF gene transduction inhibits Fas-induced liver injury and induces liver regeneration in mice: a comparative study to HGF.
Khai NC; Takahashi T; Ushikoshi H; Nagano S; Yuge K; Esaki M; Kawai T; Goto K; Murofushi Y; Fujiwara T; Fujiwara H; Kosai K
J Hepatol; 2006 Jun; 44(6):1046-54. PubMed ID: 16466829
[TBL] [Abstract][Full Text] [Related]
30. Hepatocyte growth factor-mediated cell invasion in pancreatic cancer cells is dependent on neuropilin-1.
Matsushita A; Götze T; Korc M
Cancer Res; 2007 Nov; 67(21):10309-16. PubMed ID: 17974973
[TBL] [Abstract][Full Text] [Related]
31. Transfection of human hepatocyte growth factor gene ameliorates secondary lymphedema via promotion of lymphangiogenesis.
Saito Y; Nakagami H; Morishita R; Takami Y; Kikuchi Y; Hayashi H; Nishikawa T; Tamai K; Azuma N; Sasajima T; Kaneda Y
Circulation; 2006 Sep; 114(11):1177-84. PubMed ID: 16952986
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of tumor-stromal interaction through HGF/Met signaling by valproic acid.
Matsumoto Y; Motoki T; Kubota S; Takigawa M; Tsubouchi H; Gohda E
Biochem Biophys Res Commun; 2008 Feb; 366(1):110-6. PubMed ID: 18053801
[TBL] [Abstract][Full Text] [Related]
33. Hepatocyte growth factor and c-Met expression in rat and human liver fibrosis.
Cramer T; Schuppan D; Bauer M; Pfander D; Neuhaus P; Herbst H
Liver Int; 2004 Aug; 24(4):335-44. PubMed ID: 15287857
[TBL] [Abstract][Full Text] [Related]
34. Noncompetitive inhibition of hepatocyte growth factor-dependent Met signaling by a phage-derived peptide.
Tam EM; Runyon ST; Santell L; Quan C; Yao X; Kirchhofer D; Skelton NJ; Lazarus RA
J Mol Biol; 2009 Jan; 385(1):79-90. PubMed ID: 18973760
[TBL] [Abstract][Full Text] [Related]
35. Caspase cleavage of the MET receptor generates an HGF interfering fragment.
Deheuninck J; Foveau B; Goormachtigh G; Leroy C; Ji Z; Tulasne D; Fafeur V
Biochem Biophys Res Commun; 2008 Mar; 367(3):573-7. PubMed ID: 18187039
[TBL] [Abstract][Full Text] [Related]
36. Adaptor molecule Crk is required for sustained phosphorylation of Grb2-associated binder 1 and hepatocyte growth factor-induced cell motility of human synovial sarcoma cell lines.
Watanabe T; Tsuda M; Makino Y; Ichihara S; Sawa H; Minami A; Mochizuki N; Nagashima K; Tanaka S
Mol Cancer Res; 2006 Jul; 4(7):499-510. PubMed ID: 16849525
[TBL] [Abstract][Full Text] [Related]
37. Relationship between the proliferative capability of hepatocytes and the intrahepatic expression of hepatocyte growth factor and c-Met in the course of cirrhosis development in rats.
Inoue H; Yokoyama F; Kita Y; Yoshiji H; Tsujimoto T; Deguchi A; Nakai S; Morishita A; Uchida N; Masaki T; Watanabe S; Kuriyama S
Int J Mol Med; 2006 May; 17(5):857-64. PubMed ID: 16596271
[TBL] [Abstract][Full Text] [Related]
38. Hepatocyte growth factor as well as vascular endothelial growth factor gene induction effectively promotes liver regeneration after hepatectomy in Solt-Farber rats.
Oe H; Kaido T; Mori A; Onodera H; Imamura M
Hepatogastroenterology; 2005; 52(65):1393-7. PubMed ID: 16201081
[TBL] [Abstract][Full Text] [Related]
39. Expression of hepatocyte growth factor and the proto-oncogenic receptor c-Met in canine osteosarcoma.
Fieten H; Spee B; Ijzer J; Kik MJ; Penning LC; Kirpensteijn J
Vet Pathol; 2009 Sep; 46(5):869-77. PubMed ID: 19429984
[TBL] [Abstract][Full Text] [Related]
40. c-Met responsiveness of isolated hepatocytes evaluated in an in vitro de-differentiation model.
Boost KA; Kim HJ; Engl T; Oppermann E; Jonas D; Oertl A; Blaheta RA
Int J Mol Med; 2006 Mar; 17(3):475-82. PubMed ID: 16465395
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
